A Study Examining the Effectiveness of an FDA-Approved Medication for the Treatment of Binge Eating Disorder
The 17-week, double-blind, randomized placebo-controlled trial will test the efficacy of an FDA-approved medication, liraglutide 3.0 mg/d, as compared to placebo in reducing the number of binge episodes per week, achieving remission from binge episodes, and in changes in body weight, global BED symptom improvement, and other psychological factors related ...
Weight History, Brain Activation to Food Cues and Eating Disorder Psychopathology
Drexel University and the University of Pennsylvania seek women exhibiting eating disordered behaviors for studies funded by NIH. Studies examine biological, neurological, and behavioral factors contributing to eating problems. Eligible participants attend four to five visits over six months. Compensation is provided. Call 215-762-1313 or e-mail DUeatingdisorders@drexel.edu